1. Home
  2. SGHT vs CCLD Comparison

SGHT vs CCLD Comparison

Compare SGHT & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • CCLD
  • Stock Information
  • Founded
  • SGHT 2011
  • CCLD 1999
  • Country
  • SGHT United States
  • CCLD United States
  • Employees
  • SGHT N/A
  • CCLD N/A
  • Industry
  • SGHT Medical Specialities
  • CCLD Computer Software: Prepackaged Software
  • Sector
  • SGHT Health Care
  • CCLD Technology
  • Exchange
  • SGHT Nasdaq
  • CCLD Nasdaq
  • Market Cap
  • SGHT 193.2M
  • CCLD 157.0M
  • IPO Year
  • SGHT 2021
  • CCLD 2014
  • Fundamental
  • Price
  • SGHT $3.45
  • CCLD $3.55
  • Analyst Decision
  • SGHT Buy
  • CCLD Buy
  • Analyst Count
  • SGHT 8
  • CCLD 2
  • Target Price
  • SGHT $4.21
  • CCLD $3.00
  • AVG Volume (30 Days)
  • SGHT 103.2K
  • CCLD 478.8K
  • Earning Date
  • SGHT 11-06-2025
  • CCLD 11-11-2025
  • Dividend Yield
  • SGHT N/A
  • CCLD N/A
  • EPS Growth
  • SGHT N/A
  • CCLD N/A
  • EPS
  • SGHT N/A
  • CCLD 0.00
  • Revenue
  • SGHT $76,303,000.00
  • CCLD $111,794,000.00
  • Revenue This Year
  • SGHT N/A
  • CCLD $6.94
  • Revenue Next Year
  • SGHT $12.04
  • CCLD $18.66
  • P/E Ratio
  • SGHT N/A
  • CCLD $5,166.91
  • Revenue Growth
  • SGHT N/A
  • CCLD 0.04
  • 52 Week Low
  • SGHT $2.03
  • CCLD $1.14
  • 52 Week High
  • SGHT $6.29
  • CCLD $4.84
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 42.70
  • CCLD 58.81
  • Support Level
  • SGHT $3.20
  • CCLD $3.13
  • Resistance Level
  • SGHT $3.43
  • CCLD $3.85
  • Average True Range (ATR)
  • SGHT 0.14
  • CCLD 0.19
  • MACD
  • SGHT -0.00
  • CCLD -0.00
  • Stochastic Oscillator
  • SGHT 46.79
  • CCLD 69.45

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

Share on Social Networks: